By Annette Gaudino, HCV/HIV Project Co-Director, TAG Do you remember how old you were when you stopped believing in the monster under your bed? How many times did you have to look and see nothing there before you finally believed…
By Bryn Gay, HCV Project Director, TAG Access to medicines (A2M) activists have become better coordinated, articulate, and adept in responding to pharmaceutical industry shenanigans that threaten access to affordable medicines since the establishment of harmonized global intellectual property (IP) …
By JD Davids, TAGline Guest Editor and Suraj Madoori, U.S. and Global Health Policy Director, TAG As the Trump administration makes noise about the high price of pharmaceuticals while doubling down on its commitment to “protect the engine of American…
Treatment Action Group has released a new report focusing on the ethically complex and potentially risky aspect of research aiming to develop a cure for HIV infection: the use of “analytical treatment interruptions” (ATIs) in clinical studies to investigate how HIV viral load rebounds, and whether experimental interventions can limit viral replication after antiretroviral therapy (ART) is interrupted.
This two-page brief explains TAG’s mission, gives information about TAG’s origins, describes how we work, and lists some of our many accomplishments since our founding in 1992.
I want to thank all of you for the support that enabled the successes TAG achieved this past year. Despite a challenging political climate and continued attacks against those living with or at risk of contracting HIV, tuberculosis (TB), or…
Treatment Action Group (TAG) decries the claimed use of CRISPR technology to edit genes for the HIV co-receptor CCR5 in human embryos for implantation.
October – November 2018 (Updated September 2024) Examples of media coverage: HIV cure? Major breakthrough made in eradicating deadly virus: ‘Beyond our expectations’ – Daily Star, November 1, 2018 New drug could cure HIV/Aids – Uganda Daily Monitor, November 7, 2018 Maker…
Combination antiretroviral therapy (ART) is now recommended for all people with HIV. Suppression of HIV viral load to undetectable levels by ART greatly benefits individual health—causing lifespans for many people with HIV to approach those of comparable HIV-negative individuals—and eliminates the risk of most forms of HIV transmission.
Treatment Intensification/Early Treatment AAHIV/RV254: Antiretroviral therapy for acute HIV infection NCT00796263 Establish and characterize an acute HIV infection cohort in a high-risk population NCT00796146 (related observational study) References Wietgrefe SW, Anderson J, Duan L, et al. Initial productive and latent…